Danaher (NYSE: DHR)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Danaher Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Danaher Company Info
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
News & Analysis
These exchange-traded funds track companies in this biotech space.
The best ETFs to track the water business.
On a risk/reward basis, they aren't a great value right now, but these are excellent stocks to watch for a better entry point on.
The life sciences and diagnostics company's guidance is getting complicated.
A comparison between the balance sheets of two industrial giants speaks volumes about the importance of a strong balance sheet.
The featured stocks all trade at substantial discounts to analyst price targets.
There's life after COVID-19 for Danaher, and the stock has a long pathway of growth ahead of it.
Danaher's long-term prospects are being ignored because of the near-term speculation around how long the pandemic will last.
Valuation
Earnings Transcripts
DHR earnings call for the period ending October 1, 2021.
DHR earnings call for the period ending June 30, 2021.
DHR earnings call for the period ending March 31, 2021.
DHR earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.